E2F1 and cancer: In our previous study on E2F1-driven transactivation of downstream targets and its function in cancer cells, we have shown that inhibitor of β-catenin and TCF4 (ICAT), also known as the β-catenin interacting protein 1 (CTNNBIP1), is a direct transcriptional target of E2F1 [17].